|
EULAR Updates Guidelines for Large Vessel Vasculitis
|
The European League Against Rheumatism has updated treatment guidelines for the management of large vessel vasculitis. Among the changes, the task force no longer recommends the routine use of antiplatelet or anticoagulant therapy. Learn more in this slideshow.
|
|
Read more
|
|
|
|
EULAR/ACR Treatment Guidelines for Polymyalgia Rheumatica
|
| Polymyalgia rheumatica treatment varies significantly in glucocorticoid dosages, tapering strategies and DMARD use. EULAR and ACR have published treatment recommendations. In this slideshow, we highlight the recommendations. |
|
Read more
|
|
|
|
EULAR Treatment Recommendations for the Blood Clotting Disorder APS
|
| EULAR has issued new treatment guidelines for antiphospholipid syndrome, a disorder of the immune system that causes blood clots. Among the recommendations, high risk individuals who carry the antiphospholipid antibody should take low-dose aspirin, even if they are asymptomatic. This also applies to systemic lupus erythematosus patients and women with a history of obstetric antiphospholipid syndrome. |
|
Read more
|
|
|
